This content is in French.
Laser and glaucoma: a high-pressure duel
28 janvier 2026
By Ana Espino | Published on January 28, 2026 | 3 min readGlaucoma is a chronic, progressive optic neuropathy, most often associated with elevated intraocular pressure (IOP), leading to irreversible visual field loss. It represents the second leading cause of blindness worldwide, with an increasing burden related to population aging. When medical treatments are insufficient or poorly tolerated, an
By Ana Espino | Published on January 28, 2026 | 3 min read
Glaucoma is a chronic, progressive optic neuropathy, most often associated with elevated intraocular pressure (IOP), leading to irreversible visual field loss. It represents the second leading cause of blindness worldwide, with an increasing burden related to population aging.
When medical treatments are insufficient or poorly tolerated, and surgery is not indicated, transscleral cyclophotocoagulation (TSCP) techniques may be proposed to partially destroy the ciliary body and reduce aqueous humor production. Continuous-wave TSCP (CW-TSCP), historically used, is effective but associated with significant adverse effects, particularly severe and sometimes irreversible ocular hypotony.
Glaucoma is a chronic, progressive optic neuropathy, most often associated with elevated intraocular pressure (IOP), leading to irreversible visual field loss. It represents the second leading cause of blindness worldwide, with an increasing burden related to population aging.
When medical treatments are insufficient or poorly tolerated, and surgery is not indicated, transscleral cyclophotocoagulation (TSCP) techniques may be proposed to partially destroy the ciliary body and reduce aqueous humor production. Continuous-wave TSCP (CW-TSCP), historically used, is effective but associated with significant adverse effects, particularly severe and sometimes irreversible ocular hypotony.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Gaulier A, et al. Efficacy and safety of micropulse versus continuous wave transscleral diode cyclophotocoagulation in treating glaucoma. J Fr Ophtalmol. 2025 Nov;48(9):104647
View the source
